KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Shares Issued (2016)

Bristol Myers Squibb (BMY) has disclosed Shares Issued for 8 consecutive years, with $37.0 million as the latest value for Q4 2016.

  • On a quarterly basis, Shares Issued rose 5.71% to $37.0 million in Q4 2016 year-over-year; TTM through Dec 2016 was $181.0 million, a 31.95% decrease, with the full-year FY2016 number at $181.0 million, down 31.95% from a year prior.
  • Shares Issued was $37.0 million for Q4 2016 at Bristol Myers Squibb, up from $12.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $270.0 million in Q1 2013 to a low of $12.0 million in Q3 2016.
  • A 5-year average of $88.1 million and a median of $63.5 million in 2012 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 200.0% in 2012, then plummeted 83.82% in 2014.
  • Bristol Myers Squibb's Shares Issued stood at $66.0 million in 2012, then rose by 22.73% to $81.0 million in 2013, then decreased by 27.16% to $59.0 million in 2014, then tumbled by 40.68% to $35.0 million in 2015, then increased by 5.71% to $37.0 million in 2016.
  • Per Business Quant, the three most recent readings for BMY's Shares Issued are $37.0 million (Q4 2016), $12.0 million (Q3 2016), and $61.0 million (Q2 2016).